| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Jul 07, 2022 |
|||||||||
|
Levi Strauss
LEVI
|
Q2 FY22 | $0.29 | $0.23 | $1.47B | $1.43B |
NYSE |
|||
|
Helen of Troy
HELE
|
Q1 FY23 | $2.41 | $1.94 | $508.08M | $474.17M |
NASDAQ |
|||
|
WD-40
WDFC
|
Q3 FY22 | $1.07 | $1.27 | $123.67M | $142.80M |
NASDAQ |
|||
|
Kura Sushi USA
KRUS
|
Q3 FY22 | $0.05 | -$0.10 | $37.97M | $35.54M |
NASDAQ |
|||
|
Northern Technologies International
NTIC
|
Q3 FY22 | $0.12 | $0.15 | $18.96M | $19M |
NASDAQ |
|||
|
Park Aerospace
PKE
|
Q1 FY23 | $0.09 | - | $12.78M | - |
NYSE |
|||
|
Byrna Technologies
BYRN
|
Q2 FY22 | -$0.05 | -$0.04 | $11.62M | $11.50M |
NASDAQ |
|||
|
Nurix Therapeutics
NRIX
|
- | -$1.01 | -$1.00 | $11.43M | $10.51M |
NASDAQ |
|||
|
KalVista Pharmaceuticals
KALV
|
- | -$0.98 | -$1.06 | - | - |
NASDAQ |
|||
